126 related articles for article (PubMed ID: 11836113)
1. Synthesis of a novel class of non-peptide NK-2 receptor ligand, derived from 1-phenyl-3-pyrrol-1-ylindan-2-carboxamides.
Guillon J; Dallemagne P; Léger JM; Sopkova J; Bovy PR; Jarry C; Rault S
Bioorg Med Chem; 2002 Apr; 10(4):1043-50. PubMed ID: 11836113
[TBL] [Abstract][Full Text] [Related]
2. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
[TBL] [Abstract][Full Text] [Related]
3. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin receptors in the guinea pig ileum.
Nguyen-Le XK; Nguyen QT; Gobeil F; Jukic D; Chrétien L; Regoli D
Pharmacology; 1996 Jan; 52(1):35-45. PubMed ID: 8966201
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of potential dual NK(1)/NK(3) receptor antagonists.
Hanessian S; Babonneau V; Boyer N; Mannoury la Cour C; Millan MJ; De Nanteuil G
Bioorg Med Chem Lett; 2014 Jan; 24(2):510-4. PubMed ID: 24374277
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin receptor antagonism: a patent review (2014-present).
Muñoz M; Coveñas R
Expert Opin Ther Pat; 2020 Jul; 30(7):527-539. PubMed ID: 32401556
[TBL] [Abstract][Full Text] [Related]
7. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and neurokinin antagonist activity of 2-benzylidene- and 2-benzyl-3-benzylamino quinuclidines.
Caliendo G; Greco G; Perissutti E; Santagada V; Silipo C; Vittoria A; Turbanti L; Renzetti AR; Benedetti E; Pedone C
Farmaco; 1993 Oct; 48(10):1359-78. PubMed ID: 8117379
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new 4-heteroaryl-2-phenylquinolines and their pharmacological activity as NK-2/NK-3 receptor ligands.
Borioni A; Mustazza C; Sestili I; Sbraccia M; Turchetto L; Del Giudice MR
Arch Pharm (Weinheim); 2007 Jan; 340(1):17-25. PubMed ID: 17206605
[TBL] [Abstract][Full Text] [Related]
10. Parallel solution- and solid-phase synthesis of spiropyrrolo-pyrroles as novel neurokinin receptor ligands.
Bleicher KH; Wüthrich Y; Adam G; Hoffmann T; Sleight AJ
Bioorg Med Chem Lett; 2002 Nov; 12(21):3073-6. PubMed ID: 12372504
[TBL] [Abstract][Full Text] [Related]
11. Endomorphins interact with tachykinin receptors.
Kosson P; Bonney I; Carr DB; Lipkowski AW
Peptides; 2005 Sep; 26(9):1667-9. PubMed ID: 16112408
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction.
Shirai J; Sugiyama H; Morimoto S; Maezaki H; Yamamoto Y; Okanishi S; Kamo I; Matsumoto S; Ishigami K; Inatomi N; Imanishi A; Kawamoto M; Tarui N; Hashimoto T; Ikeura Y
Bioorg Med Chem; 2012 Jan; 20(2):962-77. PubMed ID: 22189275
[TBL] [Abstract][Full Text] [Related]
13. Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction.
Stauffer SR; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
Bioorg Med Chem; 2000 Jun; 8(6):1293-316. PubMed ID: 10896109
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and NK(1)/NK(2) binding activities of a series of diacyl-substituted 2-arylpiperazines.
Blythin DJ; Chen X; Piwinski JJ; Shih NY; Shue HJ; Anthes JC; McPhail AT
Bioorg Med Chem Lett; 2002 Nov; 12(21):3161-5. PubMed ID: 12372524
[TBL] [Abstract][Full Text] [Related]
15. Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinity.
Reichard GA; Grice CA; Shih NY; Spitler J; Majmundar S; Wang SD; Paliwal S; Anthes JC; Piwinski JJ
Bioorg Med Chem Lett; 2002 Sep; 12(17):2355-8. PubMed ID: 12161132
[TBL] [Abstract][Full Text] [Related]
16. Biphenyl derivatives as novel dual NK(1)/NK(2)-receptor antagonists.
Mah R; Gerspacher M; von Sprecher A; Stutz S; Tschinke V; Anderson GP; Bertrand C; Subramanian N; Ball HA
Bioorg Med Chem Lett; 2002 Aug; 12(16):2065-8. PubMed ID: 12127505
[TBL] [Abstract][Full Text] [Related]
17. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new series of non-peptidic NK3 receptor antagonists.
Juhl K; Hansen T; Kehler J; Khanzhin NA; Nørgaard MB; Ruhland T; Larsen DB; Jensen KG; Steiniger-Brach B; Nielsen SM; Simonsen KB
Bioorg Med Chem Lett; 2011 Mar; 21(5):1498-501. PubMed ID: 21292483
[TBL] [Abstract][Full Text] [Related]
19. L-tryptophan urea amides as NK1/NK2 dual antagonists.
Qi H; Shah SK; Cascieri MA; Sadowski SJ; MaCcoss M
Bioorg Med Chem Lett; 1998 Aug; 8(16):2259-62. PubMed ID: 9873524
[TBL] [Abstract][Full Text] [Related]
20. Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety.
Giuliani G; Cappelli A; Matarrese M; Masiello V; Turolla EA; Monterisi C; Fazio F; Anzini M; Pericot Mohr G; Riitano D; Finetti F; Morbidelli L; Ziche M; Giorgi G; Vomero S
Bioorg Med Chem; 2011 Apr; 19(7):2242-51. PubMed ID: 21421318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
